研究成果以“肝骨轴缺陷促进肝性骨营养不良疾病的进展（Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression）”为题，于2022年3月1日在线发表于《细胞代谢》（Cell Metabolism） 图 PP2Acα-LCAT调控肝性骨病的发生发展的作用机制 在国家自然科学基金 ...

本研究针对现代集约化养殖中高能圈饲易致鹅发生脂肪肝和肝性骨营养不良（HOD）的问题，探讨了多年生黑麦草牧场放牧的干预效果。研究发现，放牧通过增加短链脂肪酸（SCFAs）产生，抑制肝脏蛋白磷酸酶2Acα（PP2Acα），上调卵磷脂胆固醇酰基转移酶（LCAT ...

TOULOUSE, France & LAKELAND, Mich., February 28, 2025--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a next generation biopharma company dedicated to ...

Lysosomal phospholipase A2 (LPLA2, or group XV phospholipase A2) 1 and lecithin:cholesterol acyltransferase (LCAT) 2 are closely related secreted acyltransferases that transfer a fatty acid ...

LYON, France — Researchers have, for the first time, successfully replaced the enzyme found in familial lecithin cholesterol acyltransferase (LCAT) deficiency using recombinant human LCAT ACP-501 ...

TOULOUSE, France & LAKELAND, Mich., October 21, 2024--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the ...